In a recent study, prostate cancer LNCaP-S17 cells were found to be resistant to exogenous IL-6-induced neuroendocrine differentiation and hence were less aggressive due to increased levels of CIS and SOCS7 that block activation of JAK2-STAT3 pathways [177]. The gene discussed is IL6; the disease is prostate carcinoma.